Cenk Undey Executive Director, Process DevelopmentAmgenDr. Undey joined Amgen in 2003 and has held positions of increasing responsibility in Process Development which included providing manufacturing support, continuous process improvement of commercial products, and technology transfers. He has formed the Digital Integration and Predictive Technologies in 2013, a corporate group with a mission to transform Amgen business from data rich to decision smart. His group’s aim is to improve process and product understanding, process optimization, reduce process development cycle time hence increasing speed to market with reduced development costs using Machine Learning, Smart Sensors and Computational Predictive Technologies. Dr. Undey led the introduction of real-time multivariate statistical process monitoring technology, Watson intelligent search via Natural Language Processing and various Process Analytical Technology initiatives resulting in significant business benefits. Dr. Undey and his team’s work were externally recognized receiving CIO100 Award in Life Sciences in 2013 for Amgen implementing advanced data analytical solutions. Prior to joining Amgen, Dr. Undey has worked at the Illinois Institute of Technology (IIT), Dept. of Chemical and Biological Engineering in Chicago, IL as a Sr. Postdoctoral Researcher. He has co-authored and co-edited two books, published in scientific journals and books in the areas of process systems engineering, PAT, artificial intelligence, process monitoring, control, supervision, biotechnology and bioengineering. He has received his B.Sc., M.Sc. and Ph.D. degrees all in Chemical Engineering from Istanbul University, Turkey. He also holds an Executive MBA degree from the University of California, Los Angeles, Anderson School of Management. Dr. Undey is based in the headquarters in Thousand Oaks, CA, USA.